These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20112742)

  • 1. [Identification of TGF-beta/Smads pathway in human prostate cancer cell lines and its significance].
    Wu KJ; Zhu GF; Zhang D; Zeng J; Wang XY; Xue Y; Zhang LL; He DL
    Zhonghua Nan Ke Xue; 2009 Oct; 15(10):920-4. PubMed ID: 20112742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of Smad4 in prostate cancer LNCaP and ARCaP cell lines with different metastatic potentials and its significance].
    Wu KJ; Zhang D; Zhu GF; Cheng HP; Zeng J; Zhang LL; Wang XY; He DL
    Zhonghua Nan Ke Xue; 2009 Jan; 15(1):41-4. PubMed ID: 19288748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of Wnt/beta-catenin signal pathway in human prostate cancer cell lines and its significance].
    Jiang YG; Zhao JH; Luo Y; He DL; Wang XY; Cui XH
    Zhonghua Nan Ke Xue; 2009 Apr; 15(4):310-3. PubMed ID: 19472902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expressions of E-cadherin and beta-catenin in LNCaP and ARCaP cell lines and their significance].
    Jiang YG; Zhao JH; Luo Y; He DL; Li N; Cui XH; Peng T
    Zhonghua Nan Ke Xue; 2009 Oct; 15(10):867-71. PubMed ID: 20112731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of "epithelial-mesenchymal transition" associated proteins in prostate cancer cell lines with different metastatic potentials and its significance].
    Luo Y; He DL; Ning L
    Zhonghua Nan Ke Xue; 2006 Aug; 12(8):696-700. PubMed ID: 16970156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of beta-catenin signaling pathway in EMT of human prostate cancer induced by HIF-1alpha].
    Luo Y; He DL; Jiang YG; Ning L; Shen SL; Zhao JH; Cui XH
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(16):1131-6. PubMed ID: 20646434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of COX-2 in different human prostate cancer cell lines and its significance].
    Zhao JH; Jiang YG; Wu CT; Luo Y; Hou Z; He DL
    Zhonghua Nan Ke Xue; 2010 Aug; 16(8):689-92. PubMed ID: 21090342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and significance of metastasis-associated proteins in prostate cancer cell lines with different metastatic potentials].
    Luo Y; He DL; Ning L; Zhu GD; Shen SL
    Zhonghua Nan Ke Xue; 2006 Mar; 12(3):230-3. PubMed ID: 16597039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Functional study on TGF-beta/Smads signaling pathway in human ovarian cancer cells].
    Zhang YY; Li X; Sui LH; Wang Q; Li P; Fu SB
    Yi Chuan Xue Bao; 2004 Aug; 31(8):759-65. PubMed ID: 15481528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
    Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
    Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transforming growth factor beta upregulates the expression of invasion and metastasis associated proteins in prostate cancer LNCaP cell lines in vitro].
    Zhu GF; Cheng HP; Wu KJ; Zhang LL; Zhu GD; Zhang D; He DL
    Zhonghua Nan Ke Xue; 2008 Mar; 14(3):238-41. PubMed ID: 18488338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered levels of Smad2 and Smad4 are associated with human prostate carcinogenesis.
    Perttu MC; Martikainen PM; Huhtala HS; Bläuer M; Tammela TL; Tuohimaa PJ; Syvälä H
    Prostate Cancer Prostatic Dis; 2006; 9(2):185-9. PubMed ID: 16550207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
    J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
    Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Sensibar JA; Kim JH; Kato M; Lee C
    Cancer Res; 1996 Jan; 56(1):44-8. PubMed ID: 8548772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.